Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125739733 | 12573973 | 3 | F | 20160616 | 20160706 | 20160720 | 20160722 | EXP | FR-CELGENEUS-FRA-2016071477 | CELGENE | 57.17 | YR | F | Y | 0.00000 | 20160722 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125739733 | 12573973 | 1 | PS | Thalidomide Celgene | THALIDOMIDE | 1 | Oral | N | U | 20785 | 100 | MG | CAPSULES | ||||||
| 125739733 | 12573973 | 2 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | N | U | 66188 | 1.3 | MG/M**2 | UNKNOWN | ||||||
| 125739733 | 12573973 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | N | U | 0 | 40 | MG | UNKNOWN | ||||||
| 125739733 | 12573973 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | N | U | 0 | 20 | MG | UNKNOWN | ||||||
| 125739733 | 12573973 | 5 | SS | endoxan | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | N | U | 0 | 3000 | MG/M**2 | UNKNOWN | ||||||
| 125739733 | 12573973 | 6 | SS | MESNA. | MESNA | 1 | Intravenous drip | N | U | 0 | UNKNOWN | ||||||||
| 125739733 | 12573973 | 7 | SS | ALKERAN | MELPHALAN | 1 | Intravenous drip | N | U | 0 | UNKNOWN | ||||||||
| 125739733 | 12573973 | 8 | C | VALSARTAN. | VALSARTAN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125739733 | 12573973 | 9 | C | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125739733 | 12573973 | 10 | C | Tazocillin | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125739733 | 12573973 | 1 | Plasma cell myeloma |
| 125739733 | 12573973 | 2 | Plasma cell myeloma |
| 125739733 | 12573973 | 3 | Plasma cell myeloma |
| 125739733 | 12573973 | 5 | Plasma cell myeloma |
| 125739733 | 12573973 | 6 | Plasma cell myeloma |
| 125739733 | 12573973 | 7 | Haematopoietic stem cell mobilisation |
| 125739733 | 12573973 | 8 | Product used for unknown indication |
| 125739733 | 12573973 | 9 | Pleural effusion |
| 125739733 | 12573973 | 10 | Antibiotic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125739733 | 12573973 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125739733 | 12573973 | Congestive cardiomyopathy | |
| 125739733 | 12573973 | Ejection fraction decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125739733 | 12573973 | 1 | 20151109 | 201602 | 0 | |
| 125739733 | 12573973 | 2 | 20151109 | 20160201 | 0 | |
| 125739733 | 12573973 | 3 | 20151109 | 0 | ||
| 125739733 | 12573973 | 4 | 20151109 | 0 | ||
| 125739733 | 12573973 | 5 | 20160229 | 20160229 | 0 | |
| 125739733 | 12573973 | 6 | 20160229 | 20160229 | 0 | |
| 125739733 | 12573973 | 7 | 20160409 | 20160409 | 0 | |
| 125739733 | 12573973 | 10 | 20160613 | 0 |